Get started Log in

PBLA — Panbela Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Brief: Panbela Regains Worldwide Rights To Develop And Commercialize Colon Disease Drug
11/04/2023 13:24
Brief: Panbela Announces Issuance Of New Patent In Japan Patent Is For Claims Of A Novel Process For The Production Of Sbp-101
22/03/2023 12:56
Brief: Panbela Provides Business Update And Reports Q4 And FY 2022 Financial Results
16/03/2023 22:50
Panbela Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
16/03/2023 21:43
Panbela Therapeutics Inc expected to post a loss of $3.70 a share - Earnings Preview
14/03/2023 20:50
Brief: Panbela Announces First Patient Enrolled In South Korea For Aspire Trial Studying Ivospemin In Combination With Gemcitabine and NAB-Paclitaxel In Patients With Metastatic Pancreatic Ductal Adenocarcinoma
07/03/2023 13:22
Brief: Panbela Therapeutics Inc - On Feb 9, Co Received Formal Notice From Nasdaq Stating That Co’S Scheduled Hearing Has Been Canceled
10/02/2023 21:42
Brief: Lind Global Fund II Lp Reports 9.9% Passive Stake In Panbela Therapeutics Inc As Of Jan 30
30/01/2023 21:47
U.S. STOCKS ON THE MOVE-Walt Disney, Personalis, Netflix
19/01/2023 18:54
U.S. STOCKS ON THE MOVE- NextDecade, Eli Lilly, Norwegian
19/01/2023 16:08
Panbela rises on prospects of 'orphan' tag for pancreatic cancer drug
19/01/2023 15:29
Brief: Panbela Announces Adoption Of Commission Implementing Decision From The EMA For The Orphan Designation Of Ivospemin (Sbp-101) In Combination With Gemcitabine And NAB-Paclitaxel
19/01/2023 14:01
Panbela Therapeutics rises on starting mid-stage study for type 1 diabetes drug
11/01/2023 16:26
Brief: Panbela Starts Phase II Trial Of Cpp-1X-T For Recent Onset Type I Diabetes, In Collaboration With Indiana University School Of Medicine And Jdrf
11/01/2023 14:09
Brief: Panbela Therapeutics Inc - Co Has Requested Hearing And Intends To Promptly Provide Its Plan To Regain Compliance With The Minimum Bid Price Rule
06/01/2023 21:29
Brief: Panbela Therapeutics Files Prospectus For Public Offering For Up To 4.7 Mln Shares
27/12/2022 21:22
U.S. STOCKS ON THE MOVE-Pfizer, Harrow Health, Vallon Pharma
14/12/2022 19:16
Panbela Therapeutics rises on EMA's 'orphan drug' tag for cancer drug
14/12/2022 15:39
Brief: Panbela Receives Positive EMA Opinion On Orphan Designation For Ivospemin (SBP-101)
14/12/2022 14:34
Panbela Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
10/11/2022 23:44